Form 8-K Invitae Corp For: Jan 09
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Echtzeit-Aktienkurs Invitae Corp.
Bid:
Ask:
Nachrichten zur Invitae Corp. Aktie
Invitae guides Q4 revenue above estimates
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Invitae to Present at the 41st Annual J.P. Morgan Healthcare Conference
SAN FRANCISCO, Jan. 4, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that Ken Knight,…
Align, Invitae among healthcare stocks SA contributors correctly said to avoid in 2022
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Aufsichtsrat verkauft Aktien von Invitae im Wert von 91.420$
George, Sean E. - Aufsichtsrat - Tag der Transaktion: 2022-12-16...…
Insiderhandel: Aufsichtsrat verkauft Aktien von Invitae im Wert von 23.210$
George, Sean E. - Aufsichtsrat - Tag der Transaktion: 2022-12-19...…
Form 8-K Invitae Corp For: Dec 19
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Invitae Completes Selected Assets Sale of its Next Generation Sequencing (NGS) research assays to Integrated DNA Technologies, Inc.
— Invitae will continue to invest in its precision oncology focused lab developed test (LDT) offerings — — The transaction…
Invitae Executive Appointed to National Health Information Technology Advisory Committee
– Deven McGraw to serve a 3-year term beginning in 2023 – SAN FRANCISCO, Dec. 19, 2022 /PRNewswire/ -- Invitae…
Invitae Stock: Bull vs. Bear
The bears have prevailed with Invitae this year. But could the future be better for the beaten-down stock?...…
Which Is the Better Buy: Vertex or Invitae?
Is Vertex worth its lofty valuation compared to Invitae?...…
Invitae Releases Data Use Transparency Report, Demonstrating the Impact of Patient Data on Genetic Research
– Invitae to report on secondary patient data use, demonstrating real-world impact of de-identified patient data on the advancement of…
Invitae Launches Rare Patient Network for Pediatric Patients With Rare Neurodevelopmental Diseases
– Ciitizen real-world data platform expansion helps advance research and potentially improve outcomes for patients with pediatric epilepsy and/or developmental…
Is Invitae in Danger of Running Out of Money?
The companys cash burn is improving, but its still troubling....…
Why Shares of Invitae Rose 11% on Tuesday
Investors continue to be encouraged by the companys cost-cutting attempts....…
More Likely to 5X First: Teladoc vs. Invitae
Both of these stocks have dropped more than 70% this year....…
Invitae, Pacific Biosciences up, respectively, 39% and 21% as markets surge
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why Invitae Stock Is Crushing It Today
The medical genetics company beat expectations with its Q3 results....…
Invitae (NVTA) Q3 2022 Earnings Call Transcript
NVTA earnings call for the period ending September 30, 2022....…
Could Invitae Stock Help You Retire a Millionaire?
Theres significant growth potential in the genetic testing market, but is Invitae in a good position to take advantage of…
Invitae study shows therapy informed by genetic testing reduces seizures in some patients with epilepsy
– Results support universal genetic testing in all diagnosed patients with epilepsy to potentially improve health outcomes – SAN FRANCISCO,…
Can Invitae Deliver a Positive Surprise?
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Invitae to Present Data at the American Society of Human Genetics Annual Meeting Furthering the Understanding of Variants of Uncertain Significance in Underrepresented Populations
– Presentations provide additional insights into the critical importance of advancing equity in genomics – SAN FRANCISCO, Oct. 28, 2022…
Why Invitae Stock Was So Healthy This Week
Even though the genetics testing specialist didnt divulge the financial details of a new partnership, investors nevertheless were happpy about…
Is Invitae Stock a Buy Now?
Shares have dropped more than 80% this year....…
Invitae Announces Partnership for Real-World Data Sharing to Inform Rare Cancer Research
– Using Invitaes Ciitizen patient-driven data platform, AstraZeneca and the Cholangiocarcinoma Foundation will access lived experience of patients with a…
Invitae to Announce Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
SAN FRANCISCO, Oct. 25, 2022 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it will…
Would Exact Sciences Acquire Invitae? Unlikely.
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…